Covaxin

The iNCOVACC vaccine is being offered to people over the age of 18 as a booster dose.

Drugs Controller General of India (DCGI) gave restricted emergency use authorisation to BharatBiotech's Covaxin for children between the age of 6-12 years, sources said.

A day before Covid vaccine booster shots become available to all Indian adults, the prices of Covaxin and Covishield vaccine have been slashed by more than half on Saturday.

Telangana court has directed news portal The Wire to take down 14 articles it had published on its website on biotechnology company Bharat Biotech, which manufactures Covid-19 vaccine Covaxin.

The Covid vaccines (Covaxin and Covishield) will be available at Clinics and Hospitals for sale, as per the latest approval given by the DCGI.

The World Health Organisation (WHO) on Wednesday approved Bharat Biotech’s Covaxin for emergency use listing for 18 years and above.

In a big relief for parents, the Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.

The focus of this research is to see if a person can complete the immunisation course by receiving two distinct vaccine doses, one of Covishield and one of Covaxin. 

India plans to test a combination of its own Covid-19 vaccine, Covaxin, and a prospective intranasal vaccine developed by US researchers, in the hopes of boosting the two vaccines' protective effectiveness against the virus.

According to the NIH, the findings show that the vaccine generates antibodies that successfully neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) forms of SARS-CoV-2, which were initially discovered in the UK and India, respectively.